Autochecked users, Comment administrators, Editors, Interface administrators, Reviewers, Suppressors, Administrators, Widget editors
1,874
edits
Changes
Frequently Asked Questions (FAQs) (view source)
Revision as of 14:21, 12 December 2023
, 14:21, 12 December 2023no edit summary
''There are three types of pages:''
''There are three types of pages:''
''(1) Disease category overview pages (for example see '''<u>[[Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms|Acute Myeloid Leukemia (AML)]]</u>''', which are summaries of a group of diseases with links to all relevant content.''
''(1) Disease category overview pages (for example see '''<u>[[HAEM4:Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms|Acute Myeloid Leukemia (AML)]]</u>''', which are summaries of a group of diseases with links to all relevant content.''
''(2) Disease-specific pages (for example see any of the links on the AML overview page), which is for individual disease entities and much more detailed.''
''(2) Disease-specific pages (for example see any of the links on the AML overview page), which is for individual disease entities and much more detailed.''
17. Can I modify a page that has already been completed by other authors?
17. Can I modify a page that has already been completed by other authors?
Yes! The CCGA is a wiki-based platform with the intention that contributors can modify any page at any time if something is not accurate or new evidence and references would be beneficial to share. This will allow up-to-date accurate content to be available to the community. Primary authorship will typically be listed as those individuals that initially completed the page content, and inquiries can be made by [Mailto:CCGA@cancergenomics.org <u>Email</u>] if a subsequent user modifies the content and feels the effort put forth is of high enough significance to warrant listing in the authorship section.
''Yes! The CCGA is a wiki-based platform with the intention that contributors can modify any page at any time if something is not accurate or new evidence and references would be beneficial to share. This will allow up-to-date accurate content to be available to the community. Primary authorship will typically be listed as those individuals that initially completed the page content, and inquiries can be made by [Mailto:CCGA@cancergenomics.org <u>Email</u>] if a subsequent user modifies the content and feels the effort put forth is of high enough significance to warrant listing in the authorship section.''